Clinical Trials Directory

Trials / Completed

CompletedNCT04355273

Effects of Different Concentrations of Pressurized-heparin Flushing Fluid on Coagulation and Platelet Function Monitored by the Sonoclot Analyzer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Yangzhou University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Heparin diluent or normal saline is generally used as the arterial tube flushing in clinical practice, but there is no consensus on the choice of flushing fluid. Heparin can affect the blood coagulation function, and even lead to heparin-related thrombocytopenia, increasing the risk of perioperative embolism. Sonoclot is a blood viscoelasticity test, which can provide comprehensive information on the coagulation's cascade and the entire process and be quicker and more effective than routine laboratory coagulation tests. In this research, the coagulation and platelet function analyzer called Sonoclot is used to evaluate the effect of different concentrations of pressurized heparin on the coagulation and platelet function of perioperative patients, which can provide a reference for the clinical choice of appropriate arterial flushing.

Conditions

Interventions

TypeNameDescription
DRUGHeparinheparin with a concentration of 2 U/ml is used for pressurized continuous flushing of the invasive arterial pressure monitoring tube
DRUGHeparinheparin with a concentration of 4 U/ml is used for pressurized continuous flushing of the invasive arterial pressure monitoring tube
DRUGnormal salinenormal saline is used for pressurized continuous flushing of the invasive arterial pressure monitoring tube

Timeline

Start date
2018-01-24
Primary completion
2018-02-01
Completion
2019-12-01
First posted
2020-04-21
Last updated
2020-04-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04355273. Inclusion in this directory is not an endorsement.